Open AccessSAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial
Author(s) -
Julio Rosenstock,
Dale C. Allison,
Andreas L. Birkenfeld,
Thalia Marie Blicher,
Srikanth Deenadayalan,
Jacob Jacobsen,
P. Sérusclat,
Rafael Violante,
Hirotaka Watada,
Melanie J. Davies
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-139
Subject(s) - semaglutide , sitagliptin , sulfonylurea , clinical endpoint , medicine , tolerability , discontinuation , randomized controlled trial , pharmacology , metformin , adverse effect , type 2 diabetes , endocrinology , liraglutide , insulin , diabetes mellitus